Intellectual Property India Publishes Patent Application for 'A Process For Genome-Wide Crispr Screening In Mammalian Cells' Filed by Graphic Era

MUMBAI, India, Jan. 8 -- Intellectual Property India has published a patent application (202511102462 A) filed by Graphic Era, Dehradun, Uttarakhand, on Oct. 24, 2025, for 'a process for genome-wide crispr screening in mammalian cells.'

Inventor(s) include Pallavi Singh.

The application for the patent was published on Dec. 12, under issue no. 50/2025.

According to the abstract released by the Intellectual Property India: "The present invention provides a process for genome-wide CRISPR screening in mammalian cells comprising sgRNA library (101), lentiviral delivery system (102), mammalian cell culture (103), CRISPR-Cas9 complex (104), sequencing module (105), and target gene identification output (106). The process enables accurate, reproducible, and high-throughput identification of functional genes and pathways associated with cellular phenotypes, facilitating drug target discovery and mechanistic biological studies."

Disclaimer: Curated by HT Syndication.